Translations:Insulin glargine/22/en

Revision as of 11:00, 20 March 2024 by FuzzyBot (talk | contribs) (Importing a new version from external source)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Society and culture

Legal status

Biosimilars

Abasaglar was approved for medical use in the European Union in September 2014.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Insulin_glargine/22/en&oldid=130442"